The has published a tender for "E-BID FOR RATE CONTRACT SUPPLY AND EMPANELMENT OF FIRMS FOR DRUGS AND MEDICINES" on the 14 Nov 2025. This tender belongs to Medicines category. The vendors interested in this tender and related Medicines tenders can obtain further details by exploring Tendersniper web portal. Tendersniper sends regular tender alerts by email specifically addressing the user requirements (i.e., keywords, location and value range). Government business is a growing area of opportunity. The businesses are encouraged to actively monitor tender opportunities and participate in them to grow their business.
| Tender Title | E-BID FOR RATE CONTRACT SUPPLY AND EMPANELMENT OF FIRMS FOR DRUGS AND MEDICINES |
|---|---|
| Tender Description | cyclophosphamide inj ip 200 mg [138] fluorouracil inj ip 250 mg/ 5ml [148] methotrexate tab ip 2.5 mg [154] vincristine injection ip 1 mg [159] atropine eye ointment ip 1% [319] ciprofloxacin ophthalmic ointment usp 0.3% [323] inj. ganciclovir sodium 500mg (lyophilized powder for reconstitution) [724] 3rd generation recombinant f viii 250 iu with diluent [749] leurprolide acetate depot 3.75 mg [775] gatifloxacin 0.30% and prednisolone acetate 1% ophthalmic suspension [nrd-103] hpmc 0.3% eye drop [nrd-104] voriconazole 1 % w/v (lyophilized) 30mg eye drop [nrd-119] chloramphenicol 1%, polymyxin b sulphate (10000 units) and dexamethasone 0.1% sodium phosphate eye ointment [nrd-123] carmustine 100 mg inj. ip [nrd-175] detemir insuline 100iu/ml injection 3ml [nrd-214] fludarabine phosphate injection 100mg inj. ip [nrd-237] fludarabine phosphate injection 50mg inj. ip [nrd-238] methotrexate 1000 mg inj. ip [nrd-289] inj. methylprednisolone acetate 125 mg i.p. (each vial contains methylp |
| Comments | cyclophosphamide inj ip 200 mg [138] fluorouracil inj ip 250 mg/ 5ml [148] methotrexate tab ip 2.5 mg [154] vincristine injection ip 1 mg [159] atropine eye ointment ip 1% [319] ciprofloxacin ophthalmic ointment usp 0.3% [323] inj. ganciclovir sodium 500mg (lyophilized powder for reconstitution) [724] 3rd generation recombinant f viii 250 iu with diluent [749] leurprolide acetate depot 3.75 mg [775] gatifloxacin 0.30% and prednisolone acetate 1% ophthalmic suspension [nrd-103] hpmc 0.3% eye drop [nrd-104] voriconazole 1 % w/v (lyophilized) 30mg eye drop [nrd-119] chloramphenicol 1%, polymyxin b sulphate (10000 units) and dexamethasone 0.1% sodium phosphate eye ointment [nrd-123] carmustine 100 mg inj. ip [nrd-175] detemir insuline 100iu/ml injection 3ml [nrd-214] fludarabine phosphate injection 100mg inj. ip [nrd-237] fludarabine phosphate injection 50mg inj. ip [nrd-238] methotrexate 1000 mg inj. ip [nrd-289] inj. methylprednisolone acetate 125 mg i.p. (each vial contains methylp |
| Published Date | |
|---|---|
| Due Date | 01 Dec 2025 00:00:00 |
| Estimated Value | 10.78 Crore |
|---|---|
| EMD | 0 INR |
| Processing Fee | 0 INR |